| Clinical Inquiries: How can we keep impaired glucose tolerance and impaired fasting glucose from progressing to diabetes? | |
| | |
MedLine Citation:
|
PMID: 20824232 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Lifestyle changes and some drugs can help. Lifestyle interventions aimed at weight loss of 5% to 10% of body weight along with moderate aerobic exercise such as brisk walking for 150 minutes a week are the most effective means to prevent impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) from progressing to diabetes (strength of recommendation [SOR]: A, several meta-analyses, including a recent Cochrane review). |
| | |
Authors:
|
Ana Swanson; Kerry Watrin; Laura Wilder |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The Journal of family practice Volume: 59 ISSN: 1533-7294 ISO Abbreviation: J Fam Pract Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-09-08 Completed Date: 2010-09-24 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7502590 Medline TA: J Fam Pract Country: United States |
Other Details:
|
Languages: eng Pagination: 532-3 Citation Subset: AIM; IM |
Affiliation:
|
Tacoma Family Medicine, Tacoma, Wash, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acarbose
/
therapeutic use Angiotensin-Converting Enzyme Inhibitors / therapeutic use Diabetes Mellitus, Type 2 / prevention & control* Disease Progression Glucose Intolerance / complications* Humans Hypoglycemic Agents / therapeutic use Life Style Prediabetic State / diagnosis Thiazolidinediones / therapeutic use Weight Loss |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 0/Hypoglycemic Agents; 0/Thiazolidinediones; 122320-73-4/rosiglitazone; 56180-94-0/Acarbose |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical Inquiries: Does exercise alleviate symptoms of depression?
Next Document: Clinical Inquiries: What is the best noninvasive diagnostic test for women with suspected CAD?